Building A Biotech: Exploring ILC’s Hybrid Interferon Platform

In the latest episode of the In Vivo podcast, non-executive chair Peter Bains and Owain Millington, vice president of immunology and head of preclinical, discuss ILC Therapeutics’ platform technology, financing plans as well as the pros and cons of running a startup biotech in the UK.

Episode metadata supplied by the publisher feed · Published Jan 11, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Building A Biotech: Exploring ILC’s Hybrid Interferon Platform

0:00 27:42

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Citeline Podcasts?

This episode is 27 minutes long.

When was this Citeline Podcasts episode published?

This episode was published on January 11, 2024.

Can I download this Citeline Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!